Impact of Achieving ASDAS LDA on Disease Activity and Patient-Reported Outcome Measures Among Patients with Ankylosing Spondylitis Treated with Biologic DMARDs - ACR Meeting Abstracts

Background/Purpose: Although Ankylosing Spondylitis Disease Activity Score (ASDAS) low disease activity (LDA) is a common treatment target for disease control when managing AS, real-world research describing ASDAS LDA achievement among patients treated with biologic DMARDs (bDMARD) is limited. The aim of this study was to describe disease activity and patient-reported outcome measures (PROMs) among patients […]

Safety Profile, Axial Spondyloarthritis

Efficacy and safety of upadacitinib in patients with active

Full article: Abstracts of the 37th Scandinavian Congress of

Safety Profile, Axial Spondyloarthritis

Impact of Achieving ASDAS LDA on Disease Activity and Patient

POS0905 ACHIEVEMENT OF PARTIAL REMISSION AND INACTIVE DISEASE IN

PDF) AB0002 Sirt-1 Activity in PBMC from Patients with

Dual neutralisation of interleukin-17A and interleukin-17F with

Canadian Rheumatology Association Meeting Quebec City Convention

Safety Profile, Axial Spondyloarthritis

Full article: POSTER PRESENTATIONS

ASAS-HI improvement ≥30%, ASDAS LDA status and ASAS40 response

Disease Activity-Guided Stepwise Tapering but Not Discontinuation